Lipson Adam C

Director Lipson purchases 800 shares across 3 transactions at $5.5K blended avg $6.87 amid 90d +73.3% rally; 5 of 5 prior BLTH buys achieved positive 90d returns.

Lipson Adam C (Director) executed 3 separate open-market purchases totaling 800 shares for $5,499.00 between 2025-03-27 and 2025-03-28 at a blended average price of $6.87. This acquisition occurs within a near-term momentum context: the stock has posted a 30-day change of +18.2% and a 90-day change of +73.3%, with the current price of $6.50 remaining -23.5% from the 52-week high of $8.50. Notably, Lipson's prior 5 open-market trades at BLTH all achieved positive 90-day returns, with his most recent December 2024 purchases showing 90d gains ranging from +533.3% to +1030.0%; this consistent timing pattern warrants attention against the backdrop of significant recent revenue contraction (-93.8% annual growth) and ongoing net losses ($-627,264.00 in the latest quarter). The purchase signals continuation of a demonstrated pattern of accumulation at this security, though the fundamental deterioration and unprofitable status merit independent verification of underlying catalysts.

Director Adam C Lipson bought 2,224 shares at blended average $1.35; stock up +307.4% in 90 days, company down -93.8% annual revenue.

Adam C Lipson, a Director, made 2 separate purchases totaling 2,224 shares for $3,002.40, increasing his holdings from 312,747 to 314,971 shares (+0.7%). The transactions occurred at prices of $2.40 (2023-05-22) and $0.30 (2024-05-22), producing a blended average of $1.35, well below the current price of $5.50. The stock has rallied +307.4% over the 90-day period preceding this filing, yet the company's fundamentals remain severely distressed: annual revenue contracted -93.8%, latest quarterly revenue stands at $49.8K, the market cap is only $65.6K, and the company posted a full-year net loss of $-627.3K. His cross-ticker track record shows 5 prior buys with an average 30-day return of +314.9%, but prior BLTH purchases lack measurable 90-day outcomes to assess timing discipline at this specific ticker. The combination of aggressive price-momentum gains, deteriorating revenue fundamentals, and extreme balance-sheet stress creates material tension between the buy signal and operational reality.

Director Lipson bought 7,000 shares at $0.77 on 2024-12-23; stock now at $3.20, up 137.0% in 30 days

Adam C Lipson (Director) purchased 7,000 shares of BLTH at $0.77 on 2024-12-23, increasing his holdings to 1,619,533 shares. The stock has rallied to $3.20 from the transaction price, reflecting a gain of 137.0% in 30 days and 128.6% in 90 days, which extends a strong recent price momentum from a 52-week low of $0.16. However, the company faces severe operational headwinds: revenue contracted 93.8% year-over-year to $49,773 in the latest quarter, with a net loss of $627,264 and a market cap of only $38,181.98. This transaction occurs amid rapid-fire accumulation—Lipson completed four other purchases at BLTH within the prior five days (2024-12-12, -18, -19, -20), with his May 2024 purchase in the same stock showing an ex post 90-day return of +716.7%. While cross-ticker track record shows strong average timing (100% win rate over 90 days with 652.1% average return), the company's dramatic revenue collapse and negative profitability raise material questions about the sustainability of the recent price spike and the fundamental driver of director accumulation in a deeply unprofitable, revenue-declining business.

Director Adam C Lipson bought 5,000 shares of BLTH at $0.50 on 2024-12-12; extends pattern of well-timed purchases at this ticker.

Adam C Lipson, a director at American Battery Materials, purchased 5,000 shares at $0.50, extending a consistent pattern: both of his prior BLTH purchases in 2023 and 2024 were followed by substantial 90-day gains (587.5% and 716.7% respectively). His cross-ticker track record shows 2 prior buys with an average 90d return of +652.1% and a 100% win rate, though this new purchase at BLTH comes as the stock trades at $1.35, down 80.7% from its 52-week high and falling 10% over the past 30 days. The company faces severe headwinds: revenue collapsed 93.8% year-over-year to $49.8K in the latest quarter, the company generated a $627.3K net loss, market cap stands at $16.1K, and it remains unprofitable. An insider with a demonstrated ability to time entry points is buying into a severely distressed micro-cap at a price 73% below its recent trading peak, suggesting conviction despite deteriorating fundamentals.